CymaBay Therapeutics Inc. EPS - Earnings per Share 2013-2023 | CBAY
CymaBay Therapeutics Inc. eps - earnings per share from 2013 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| CymaBay Therapeutics Inc. Annual EPS |
| 2023 |
$-0.99 |
| 2022 |
$-1.21 |
| 2021 |
$-1.27 |
| 2020 |
$-0.74 |
| 2019 |
$-1.53 |
| 2018 |
$-1.26 |
| 2017 |
$-0.79 |
| 2016 |
$-1.14 |
| 2015 |
$-0.83 |
| 2014 |
$-2.65 |
| 2013 |
$-3.54 |
| 2012 |
$-4,128.71 |
| CymaBay Therapeutics Inc. Quarterly EPS |
| 2023-12-31 |
$-0.37 |
| 2023-09-30 |
$-0.32 |
| 2023-06-30 |
$-0.01 |
| 2023-03-31 |
$-0.29 |
| 2022-12-31 |
$-0.30 |
| 2022-09-30 |
$-0.28 |
| 2022-06-30 |
$-0.31 |
| 2022-03-31 |
$-0.32 |
| 2021-12-31 |
$-0.35 |
| 2021-09-30 |
$-0.33 |
| 2021-06-30 |
$-0.34 |
| 2021-03-31 |
$-0.25 |
| 2020-12-31 |
$-0.22 |
| 2020-09-30 |
$-0.17 |
| 2020-06-30 |
$-0.16 |
| 2020-03-31 |
$-0.19 |
| 2019-12-31 |
$-0.43 |
| 2019-09-30 |
$-0.38 |
| 2019-06-30 |
$-0.35 |
| 2019-03-31 |
$-0.37 |
| 2018-12-31 |
$-0.30 |
| 2018-09-30 |
$-0.34 |
| 2018-06-30 |
$-0.30 |
| 2018-03-31 |
$-0.32 |
| 2017-12-31 |
$-0.07 |
| 2017-09-30 |
$-0.21 |
| 2017-06-30 |
$-0.31 |
| 2017-03-31 |
$-0.20 |
| 2016-12-31 |
$-0.30 |
| 2016-09-30 |
$-0.25 |
| 2016-06-30 |
$-0.30 |
| 2016-03-31 |
$-0.29 |
| 2015-12-31 |
$-0.03 |
| 2015-09-30 |
$-0.27 |
| 2015-06-30 |
$-0.09 |
| 2015-03-31 |
$-0.44 |
| 2014-12-31 |
$-0.63 |
| 2014-09-30 |
$-0.44 |
| 2014-06-30 |
$-0.56 |
| 2014-03-31 |
$-1.02 |
| 2013-12-31 |
$1,900.90 |
| 2013-09-30 |
$-1.79 |
| 2013-06-30 |
$-917.59 |
| 2013-03-31 |
$-985.06 |
| 2012-12-31 |
$0.00 |
| 2012-09-30 |
$-637.50 |
